Status | Study |
Recruiting |
Study Name: Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) Condition: Leukemia, Adult T-Cell HTLV I Associated T Cell Leukemia Date: 2016-02-20 Interventions: Biological: IL-15 plus alemtuzumab rhIL-15 by s.c. injection Monday-Friday over two weeks; followed by a |
Recruiting |
Study Name: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma Condition: Adult Nasal Type Extranodal NK/T-Cell Lymphoma Adult T-Cell Leukemia/L Date: 2016-01-08 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma Condition: Acute Adult T-Cell Leukemia/Lymphoma Adul Date: 2015-12-15 Interventions: Other: Laboratory Biomarker Analysis |
Active, not recruiting |
Study Name: Evaluation and Treatment of Tall Statured Girls Condition: Constitutional Tall Stature Date: 2015-12-13 Interventions: Drug: Estradiol Estradiol containing compounds administered orally in a non-randomized manner. |
Recruiting |
Study Name: A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) Condition: T-cell Lymphoma Angioimmunoblastic T-cell Lymphoma Hepato- Date: 2015-10-26 Interventions: Drug: Brentuximab vedotin study drug given intravenously to determine efficacy in study diseases |
Recruiting |
Study Name: A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL Condition: T-cell Acute Lymphoblastic Leukemia T-cell Lymphoblastic Lymphoma Date: 2015-08-05 Interventions: Drug: LY3039478 Administered o |
Active, not recruiting |
Study Name: Romidepsin Maintenance After Allogeneic Stem Cell Transplantation Condition: Cutaneous T-cell Lymphoma T-Prolymphocytic Leukemia T-Larg Date: 2015-07-29 Interventions: Drug: Romidepsin |
Recruiting |
Study Name: CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Condition: Peripheral T-Cell Lymphoma Angioimmunoblastic T Cell Lymphoma Date: 2015-07-18 Interventions: Drug: CEOP/IVE/GDP chemotherapy regimen |
Recruiting |
Study Name: CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma Condition: Adult Lymphocyte Depletion Hodgkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Date: 2014-06-18 Interventions: Drug: 6,8-bis(benzylthio)octanoic acid |
Recruiting |
Study Name: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Condition: Adult T Acute Lymphoblastic Leukemia Childhood T Acute Lymphoblastic Leukemia Date: 2014-04-09 Interventions: Drug: Bortezomib Given IV |